EGFR/ErbB-2/ErbB-4 inhibitor-2 | MedChemExpress (MCE)

EGFR/ErbB-2/ErbB-4 inhibitor-2 产品活性：EGFR/ErbB-2/ErbB-4 inhibitor-2 (Compound 5) 是一种 EGFR 和 ErbB 抑制剂，IC50 分别为 0.017 μM，0.08 μM，1.91 μM。 产品来源： https://www.medchemexpress.cn/egfr-erbb-2-erbb-4-inhibitor-2.html 研究领域：JAK/STAT Signaling | Protein Tyrosine Kinase/RTK 作用靶点：EGFR In Vitro: EGFR/ErbB-2/ErbB-4 inhibitor-2 (Compound 5) also inhibits c-Src, VEGFR2, c-Fms and with IC50s of 0.30, 2.2, and 14.0 μM, respectively. 相关产品：Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | JAK/STAT Compound Library | Kinase Inhibitor Library | Protein Tyrosine Kinase Compound Library | Anti-Cancer Compound Library | Differentiation Inducing Compound Library | Anti-Hepatitis C Virus Compound Library | Anti-Breast Cancer Compound Library | Anti-Lung Cancer Compound Library | Anti-Pancreatic Cancer Compound Library | Anti-Obesity Compound Library | Angiogenesis-Related Compound Library | Targeted Diversity Library | Anti-Liver Cancer Compound Library | Anti-Colorectal Cancer Compound Library | Anti-Prostate Cancer Compound Library | Cancer Stem Cells Compound Library | Heterocyclic Compound Library | Membrane Protein-targeted Compound Library | Membrane Receptor-targeted Compound Library | Highly Selective Inhibitors Library | Cytokine Inhibitors Library | Anti-Ovarian Cancer Compound Library | Multi-Target Compound Library | Bioactive Compound Library Max | Anti-Gastric Cancer Compound Library | Osimertinib | Trastuzumab | Gefitinib | Cetuximab | Erlotinib | Afatinib | Trastuzumab deruxtecan | Lapatinib | AG490 | Genistein | Neratinib | Trastuzumab emtansine | Tucatinib | Dacomitinib | AG-1478 | Pertuzumab | Disitamab vedotin | Mobocertinib | NSC 228155 | Amivantamab | Sapitinib | Pyrotinib | Firmonertinib mesylate | BLU-945 | Patritumab | Lazertinib | Panitumumab 品牌介绍: MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供最新最全的高品质小分子活性化合物；10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；设有专业的实验中心和严格的质控、验证体系；提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；产品的生物活性多经各国客户实验验证；Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果；专业团队跟踪最新的制药及生命科学研究进展，为您提供全球最新的活性化合物；与世界各大制药公司及知名科研机构建立了长期的合作。

EGFR/ErbB-2/ErbB-4 inhibitor-2 | MedChemExpress (MCE)信息由MedChemExpress (MCE)为您提供，如您想了解更多关于EGFR/ErbB-2/ErbB-4 inhibitor-2 | MedChemExpress (MCE)报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途